Can smarter remote monitoring keep heart failure patients out of the hospital?
NCT ID NCT03012490
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 652 heart failure patients who had a special heart device (CRT). One group received standard remote monitoring, while the other got more detailed monitoring that also tracked heart rhythm issues and symptoms. The goal was to see if the extra monitoring could reduce deaths or hospital visits for worsening heart failure over 27 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
remote monitoring (comprehensive vs standard)
What this could lead to
If successful, this could show that more detailed remote monitoring helps heart failure patients live longer and avoid hospital stays.
What could go wrong
This trial is already completed, so results are known. The approach may not significantly improve outcomes over standard care, and benefits may vary by patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut coeur poumon, CHRU
Lille, France